Hatchtech Pty Ltd
Research - Melbourne, Victoria, Australia
Hatchtech Pty Ltd Employees
Hatchtech Pty Ltd Details
Hatchtech Pty Ltd is an innovative biotechnology company developing novel solutions for everyday health problems based in Melbourne, Australia. Its lead development product, Xeglyze™ Lotion (formerly DeOvo™ Lotion), is a single dose, single treatment, topical prescription product for the control of head lice. The treatment works by killing both the lice and the eggs in one application. While existing head lice treatments treat the lice, few are highly effective against the eggs hence repeat applications and ‘nit combing' are needed to eliminate an infestation. Additionally, whilst head lice have developed resistance to many of the current products on the market, the novel mode of action of Xeglyze™ effectively means resistance is unlikely to develop.In 2015, the company signed a multi-country commercialization agreement for Xeglyze™ with integrated pharmaceutical company Dr. Reddy's Laboratories (NYSE: RDY). Xeglyze™ has completed clinical development, and a New Drug Application has been filed with the US Food and Drug Administration (FDA). If approved, the product will be marketed in the United States by Promius Pharma, a wholly-owned specialty company of Dr. Reddy's Laboratories.Hatchtech is led by an experienced team of pharmaceutical and biotechnology executives with demonstrated success in product development, gaining FDA approval, licensing and commercialization. Investors include some of the largest and most influential life sciences investors in Australia.
Hatchtech Pty Ltd Technologies
Email Providers
Outlook
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly